EQUR E-QURE Corp.

E-QURE Corp. engages in providing medical devices. Its product includes the Bioelectrical Signal Therapy, which is used to treat chronic wounds which include Diabetic Foot Ulcers, Pressure (Decubitus) Ulcers and Vascular (Arterial and Venous) Leg Ulcers. The company was founded on August 31, 1988 and is headquartered in New York, NY.

This security is traded over-the-counter, or OTC. We don't always have accurate pricing data on OTC stocks.

$0.04    OTCQB
As of 01/25/2022     OTCMarkets


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Unknown
Industry:  Medical Devices
Index country:  USA
Country of incorporation:  
IPO date:  07/13/2001
Outstanding shares:  34,546,243
Average volume:  27,980
Market cap:   $1,520,035
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   -8.80
PS ratio:   0.00
Return on equity:   118.03%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy